Study guide

3.1 Respiratory Mechanics, Lung Volumes, and Work of Breathing

EDAIC Part I European Diploma in Anaesthesiology and Intensive Care

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: The EDAIC Part I Examination

1.1 EDAIC Part I Exam Format, Scoring and Multiple True/False Strategy

2 Chapter 2: Anatomy for Anaesthesia and Intensive Care

2.1 Functional Anatomy of the Upper Airway, Larynx, and Tracheobronchial Tree 2.2 Neuraxial Anatomy: Spine, Spinal Cord, Meninges, and Spaces 2.3 Vascular Anatomy for Central and Peripheral Cannulation 2.4 Peripheral Nerve Plexuses and Autonomic Nervous System Pathways 2.5 Thoracic Anatomy: Chest Wall, Intercostal Spaces, Pleura, Mediastinum and Heart

3 Chapter 3: Respiratory and Cardiovascular Physiology

3.1 Respiratory Mechanics, Lung Volumes, and Work of Breathing 3.2 Ventilation-Perfusion Relationships, Shunt, and Gas Exchange 3.3 Control of Breathing, Hypoxia, Altitude and Hyperbaric Physiology 3.4 Cardiac Cycle, Electrophysiology, and Ventricular Function 3.5 Vascular Resistance, Microcirculation, and Systemic Hemodynamics

4 Chapter 4: Neurophysiology, Renal, Hepatic and Acid-Base Physiology

4.1 Cerebral Blood Flow, Intracranial Pressure, and CSF Dynamics 4.2 Renal Physiology, Glomerular Filtration, and Tubular Transport 4.3 Hepatic Blood Flow, Metabolism, and Clearance 4.4 Acid-Base Regulation, Buffering Systems, and Stewart Approach

5 Chapter 5: Endocrine and Haematological Physiology

5.1 Endocrine Physiology and the Neuroendocrine Stress Response 5.2 Haemostasis Physiology, Coagulation Testing and Inherited Bleeding Disorders

6 Chapter 6: Special Patient Physiology: Maternal, Paediatric and Geriatric

6.1 Maternal Physiological Adaptations to Pregnancy and Uteroplacental Flow 6.2 Neonatal and Paediatric Physiological Differences 6.3 Physiological Changes of Ageing and Thermoregulation

7 Chapter 7: General Pharmacological Principles and Inhalational Anaesthetics

7.1 Pharmacokinetic Principles, Compartmental Models, and Clearance 7.2 Pharmacodynamic Mechanisms, Receptor Theory, and Drug Interactions 7.3 Physical Properties, Uptake, and Distribution of Volatile Anaesthetics 7.4 Minimum Alveolar Concentration (MAC), Organ Effects, and Toxicity

8 Chapter 8: Intravenous Agents, Neuromuscular Blockade and Analgesics

8.1 Intravenous Induction Agents: Propofol, Etomidate, Ketamine, and Barbiturates 8.2 Neuromuscular Blocking Agents: Depolarizing and Non-Depolarizing Drugs 8.3 Neuromuscular Monitoring and Reversal: Anticholinesterases and Sugammadex 8.4 Opioid Pharmacology, Receptors, and Non-Opioid Analgesic Agents

9 Chapter 9: Cardiovascular Drugs, Autonomic Pharmacology and Local Anaesthetics

9.1 Inotropes, Vasopressors, and Inodilators in Perioperative Care 9.2 Antiarrhythmic, Antihypertensive, and Beta-Adrenergic Antagonist Drugs 9.3 Local Anaesthetic Pharmacology, Toxicity (LAST), and Lipid Emulsion Therapy

10 Chapter 10: Haematological and Internal Medicine Pharmacology

10.1 Anticoagulant, Antiplatelet and Haemostatic Drugs and Their Reversal 10.2 Internal Medicine Drugs: Endocrine, Respiratory, Psychiatric and Antiepileptic Agents and Their Anaesthetic Interactions

11 Chapter 11: Physics, Clinical Measurement and Medical Equipment

11.1 Physical Gas Laws, Fluid Dynamics, and Resistance Principles 11.2 Anaesthetic Machines, Gas Supply Pipelines, Cylinders, and Safety Mechanisms 11.3 Breathing Systems, Vaporizer Mechanics, and Scavenging Systems 11.4 Invasive and Non-Invasive Hemodynamic and Respiratory Monitoring

12 Chapter 12: Electrical Safety, Temperature, Humidity and Gas Analysis

12.1 Electricity, Electrical Safety, Diathermy, Defibrillation, Implanted Devices and Fire 12.2 Temperature Measurement, Humidity, Gas Analysis and SI Units

13 Chapter 13: Biostatistics, Clinical Trials and Evidence Appraisal

13.1 Descriptive Statistics, Distributions, and Parametric vs Non-Parametric Tests 13.2 Hypothesis Testing, Power, Type I/II Errors, and Confidence Intervals 13.3 Clinical Study Designs, Bias, and Diagnostic Test Performance (Sensitivity, Specificity, ROC)

14 Chapter 14: General Anaesthesia, Preoperative Evaluation and Airway Management

14.1 Preoperative Risk Assessment, Cardiovascular Risk Indices, and Fasting Guidelines 14.2 The Difficult Airway: Assessment, Algorithms, and Rescue Oxygenation 14.3 Intraoperative Fluid Therapy, Goal-Directed Hemodynamics, and Blood Conservation 14.4 Post-Anaesthesia Care Unit (PACU) Management, Emergence, and Postoperative Nausea/Vomiting

15 Chapter 15: Coexisting Disease and Preoperative Investigations

15.1 Interpreting Investigations: ECG, Chest Radiograph, Lung Function and Blood Tests 15.2 Coexisting Disease I: Asthma, COPD, Obstructive Sleep Apnoea, Obesity, Liver and Renal Disease 15.3 Endocrine Disease and Emergencies: Diabetes, DKA and HHS, Thyroid, Adrenal, Phaeochromocytoma and Carcinoid 15.4 Coexisting Disease II: Neuromuscular and Neurological Disease

16 Chapter 16: Subspecialty Anaesthesia: Cardiothoracic, Vascular and Neuroanaesthesia

16.1 Anaesthesia for Cardiac Surgery and Cardiopulmonary Bypass Management 16.2 Thoracic Anaesthesia, One-Lung Ventilation, and Major Vascular Surgery 16.3 Neuroanaesthesia: Craniotomy, Sitting Position, and Traumatic Brain Injury

17 Chapter 17: Obstetric, Paediatric and Ambulatory Anaesthesia

17.1 Obstetric Analgesia and Anaesthesia: Labour, Caesarean Delivery, and High-Risk Conditions 17.2 Paediatric Anaesthesia: Induction, Airway Management, and Emergencies 17.3 Ambulatory Day-Surgery Selection, Premedication, and Elderly Patient Anaesthesia

18 Chapter 18: Anaesthetic Complications and Specialty Settings

18.1 Anaesthetic Complications: Accidental Awareness, Aspiration, Positioning Injuries, Visual Loss and Dental Damage 18.2 Anaesthesia for ENT and Laser Airway Surgery, Ophthalmic Surgery, and Laparoscopic and Robotic Surgery

19 Chapter 19: Regional Anaesthesia and Acute/Chronic Pain Management

19.1 Neuraxial Techniques: Spinal, Epidural, and Caudal Anaesthesia 19.2 Upper and Lower Limb Peripheral Nerve and Fascial Plane Blocks 19.3 Multimodal Acute Postoperative Pain Management and ERAS Pathways 19.4 Chronic and Neuropathic Pain Syndromes and Interventional Management 19.5 Palliative Symptom Control, Psychological Aspects of Pain and Multidisciplinary Pain Management

20 Chapter 20: Intensive Care Medicine: Ventilation, Shock and Organ Support

20.1 Acute Respiratory Distress Syndrome (ARDS) and Mechanical Ventilation Strategies 20.2 Sepsis-3 Definitions, Septic Shock, and Hemodynamic Resuscitation 20.3 Acute Kidney Injury, Indications for Dialysis, and Continuous Renal Replacement Therapy 20.4 ICU Sedation, Delirium, Weaning, and Brain Death Determination

21 Chapter 21: Intensive Care Medicine: Admission, Nutrition, Infection and Electrolytes

21.1 ICU Admission, Severity Scoring, Nutrition and Routine Prophylaxis 21.2 Antimicrobial Therapy, Stewardship and ICU-Acquired Infections 21.3 Electrolyte Disorders: Sodium, Potassium, Calcium, Magnesium and Phosphate

22 Chapter 22: Intensive Care and Emergency Medicine: Neurocritical Care, Poisoning and Cardiorespiratory Emergencies

22.1 Neurocritical Care: Subarachnoid Haemorrhage, Stroke, Status Epilepticus and Acute Neuromuscular Failure 22.2 Acute Poisoning: Toxidromes, Decontamination and Specific Antidotes 22.3 Acute Cardiorespiratory Emergencies: Pulmonary Embolism, Acute Severe Asthma and COPD, Non-Invasive Support and Acute Heart Failure

23 Chapter 23: Resuscitation, Perioperative Emergencies and Professional Ethics

23.1 Advanced Life Support (ALS) Guidelines and Perioperative Cardiac Arrest 23.2 Perioperative Crises: Malignant Hyperthermia and Severe Anaphylaxis 23.3 Major Trauma, Hemorrhagic Shock, and Massive Transfusion Protocols 23.4 Professional Ethics, Informed Consent, Patient Safety, and Helsinki Declaration

24 Chapter 24: Newborn, Paediatric and Obstetric Emergencies

24.1 Newborn Life Support and Paediatric Life Support 24.2 Obstetric Emergencies: Maternal Collapse, Amniotic Fluid Embolism, Uterine Inversion and Resuscitative Hysterotomy

25 Chapter 25: Burns, Environmental Emergencies and Patient Transport

25.1 Burns, Inhalation Injury, Drowning, Hypothermia, Heat Illness and Decompression Illness 25.2 Prehospital Care and Intra- and Inter-Hospital Transport of the Critically Ill

3.1 Respiratory Mechanics, Lung Volumes, and Work of Breathing

Key Takeaways Explain This Topic AI

Functional Residual Capacity (FRC ≈ 30 mL/kg \approx 30\text{ mL/kg} ≈ 30 mL/kg or 2.4 L 2.4\text{ L} 2.4 L in a 70 kg adult) represents the resting volume where outward chest wall recoil balances inward lung recoil; spirometry cannot measure FRC, Residual Volume (RV ≈ 1.2 L \approx 1.2\text{ L} ≈ 1.2 L ), or Total Lung Capacity (TLC ≈ 6.0 L \approx 6.0\text{ L} ≈ 6.0 L ), necessitating helium dilution, nitrogen washout, or body plethysmography.

Induction of general anaesthesia triggers an immediate 15–20% loss of FRC due to diaphragmatic tone cessation and cephalad visceral shift, compounding the 0.5–1.0 L reduction caused by the supine position; when Closing Capacity (CC) exceeds FRC, dependent small airways collapse during tidal breathing, generating atelectasis and shunt.

Static compliance ( C stat = V T P plat − PEEP C_{\text{stat}} = \frac{V_T}{P_{\text{plat}} - \text{PEEP}} C stat ​ = P plat ​ − PEEP V T ​ ​ ) isolates respiratory system elastance ( E = 1 / C E = 1/C E = 1/ C ), whereas dynamic compliance ( C dyn = V T P peak − PEEP C_{\text{dyn}} = \frac{V_T}{P_{\text{peak}} - \text{PEEP}} C dyn ​ = P peak ​ − PEEP V T ​ ​ ) also reflects resistive pressure dissipation driven by airway caliber according to the Hagen-Poiseuille relationship ( R ∝ 8 η l π r 4 R \propto \frac{8\eta l}{\pi r^4} R ∝ π r 4 8 η l ​ ).

Pulmonary surfactant (predominantly dipalmitoylphosphatidylcholine, DPPC), synthesized by Type II pneumocytes, dynamically lowers alveolar surface tension as alveolar radius contracts, preventing small alveolar collapse and fluid transudation in accordance with the Law of Laplace ( P = 2 T r P = \frac{2T}{r} P = r 2 T ​ ).

Last updated: October 2026

3.1 Respiratory Mechanics, Lung Volumes, and Work of Breathing

Mastery of respiratory mechanics is essential for managing positive pressure ventilation, predicting perioperative gas exchange failure, and preventing ventilator-induced lung injury (VILI). This section examines lung volumes, compliance, airway resistance, and surfactant biophysics.

1. Static and Dynamic Lung Volumes and Capacities

Lung volumes are partitioned into four discrete primary volumes and four composite capacities (combinations of two or more primary volumes). Standard physiological values apply to a healthy 70 kg 70\text{ kg} 70 kg adult male. [ TOTAL LUNG CAPACITY (TLC ~6.0 L) ]

  • +-------------------------------------------------------------------+
  • | Inspiratory Reserve Volume (IRV ~3.0 L) |
  • | |
  • +---------------------------------+---------------------------------+
  • | Tidal Volume (TV ~0.5 L) | Inspiratory Capacity |
  • +---------------------------------+ (IC = TV + IRV ~3.5 L) |
  • | Expiratory Reserve Vol (~1.1 L)| |
  • +---------------------------------+---------------------------------+
  • | Residual Volume (RV ~1.2 L) | Functional Residual Capacity |
  • | (Cannot be exhaled) | (FRC = ERV + RV ~2.4 L) |
  • +---------------------------------+---------------------------------+
  • [ VITAL CAPACITY (VC = IRV + TV + ERV ~4.6 L) ]
  • Primary Lung Volumes

Tidal Volume ( V T V_T V T ​ or TV): Volume of gas inspired or expired during quiet, normal breathing ( 500 mL 500\text{ mL} 500 mL or 6 − 8 mL/kg 6-8\text{ mL/kg} 6 − 8 mL/kg ideal body weight).

Inspiratory Reserve Volume (IRV): Maximal additional volume of gas inspired from the end of a normal tidal inspiration (approximately 2.5 − 3.0 L 2.5-3.0\text{ L} 2.5 − 3.0 L ).

Expiratory Reserve Volume (ERV): Maximal volume of gas that can be actively exhaled after the end of a resting tidal expiration (approximately 1.0 − 1.2 L 1.0-1.2\text{ L} 1.0 − 1.2 L ).

Residual Volume (RV): Volume of gas remaining in the lungs after a maximal forced expiration (approximately 1.2 L 1.2\text{ L} 1.2 L or 15 − 20 mL/kg 15-20\text{ mL/kg} 15 − 20 mL/kg ). RV is determined by the balance between expiratory muscle effort and dynamic airway compression/chest wall rigidity.

Composite Lung Capacities

Functional Residual Capacity (FRC): Gas volume remaining in the lungs at the end of a passive tidal expiration ( F R C = E R V + R V ≈ 2.4 L FRC = ERV + RV \approx 2.4\text{ L} FRC = ER V + R V ≈ 2.4 L or ≈ 30 mL/kg \approx 30\text{ mL/kg} ≈ 30 mL/kg ). At FRC, the inward elastic recoil of the lungs exactly balances the outward elastic recoil of the chest wall (the resting equilibrium position of the respiratory system).

Inspiratory Capacity (IC): Maximal volume inspired from the resting end-expiratory level ( I C = V T + I R V ≈ 3.5 L IC = V_T + IRV \approx 3.5\text{ L} I C = V T ​ + I R V ≈ 3.5 L ).

Vital Capacity (VC): Maximal volume of gas exhaled after a maximal inspiration ( V C = I R V + V T + E R V ≈ 4.5 − 4.8 L VC = IRV + V_T + ERV \approx 4.5-4.8\text{ L} V C = I R V + V T ​ + ER V ≈ 4.5 − 4.8 L or 60 − 70 mL/kg 60-70\text{ mL/kg} 60 − 70 mL/kg ).

Total Lung Capacity (TLC): Total volume of gas contained in the lungs at maximal inspiration ( T L C = V C + R V ≈ 6.0 L TLC = VC + RV \approx 6.0\text{ L} T L C = V C + R V ≈ 6.0 L ). Determined by the balance between inspiratory muscle force and the inward recoil of the lung and chest wall.

Measurement Principles and Limitations of Spirometry

Spirometry records the movement of gas into and out of the lungs over time. Consequently, spirometry can measure only mobilizable gas volumes ( V T V_T V T ​ , IRV, ERV, IC, and VC).

Critical Examination Distinction: Spirometry cannot measure any volume or capacity that contains the Residual Volume ( R V RV R V , F R C FRC FRC , and T L C TLC T L C ). To measure these absolute thoracic volumes, three specialized techniques are utilized:

Technique Physical Principle Key Equation / Mechanism Clinical Advantage / Limitation

Helium Dilution Closed-circuit gas rebreathing C 1 V 1 = C 2 ( V 1 + FRC ) C_1 V_1 = C_2 (V_1 + \text{FRC}) C 1 ​ V 1 ​ = C 2 ​ ( V 1 ​ + FRC ) Measures only gas in communication with the conducting airways. Underestimates FRC in bullous emphysema or severe airway obstruction.

Nitrogen Washout Open-circuit 100 % O 2 100\%\text{ O}_2 100% O 2 ​ breathing FRC = V E × C E ˉ N 2 0.79 − C end N 2 \text{FRC} = \frac{V_E \times C_{\bar{E}\text{N}_2}}{0.79 - C_{\text{end}\text{N}_2}} FRC = 0.79 − C end N 2 ​ ​ V E ​ × C E ˉ N 2 ​ ​ ​ Measures only ventilated gas spaces. Underestimates FRC when significant gas trapping is present.

Body Plethysmography Boyle's Law at constant temperature P 1 V 1 = P 2 V 2 P_1 V_1 = P_2 V_2 P 1 ​ V 1 ​ = P 2 ​ V 2 ​ Measures total thoracic gas volume (TGV) , including non-communicating bullae, blebs, and trapped gas behind obstructed airways. Considered the gold standard.

  • 2. Functional Residual Capacity (FRC) and Closing Capacity (CC)
  • The Physiology of FRC

At FRC, the respiratory system is in static equilibrium: alveolar pressure ( P A P_A P A ​ ) is zero relative to atmospheric pressure, and the outward spring of the thoracic cage matches the inward collapse tendency of the alveolar elastic fibers. Under normal conditions, intrapleural pressure ( P p l P_{pl} P pl ​ ) at FRC is negative, averaging ≈ − 5 cmH 2 O \approx -5\text{ cmH}_2\text{O} ≈ − 5 cmH 2 ​ O . [ CHEST WALL ] [ LUNG TISSUE ]

  • Outward Elastic Recoil Inward Elastic Recoil
  • <=== ===>
  • \ /
  • \-- Intrapleural Space (~ -5 cmH2O) -/
  • |
  • [ FRC Equilibrium Point ]

FRC functions as an essential oxygen buffer. Because pulmonary capillary blood flow is continuous across the entire cardiac cycle, alveolar oxygen stored in the FRC sustains systemic arterial oxygenation during the expiratory pause and prevents arterial desaturation during periods of transient apnea (e.g. tracheal intubation).

Factors Reducing FRC

Body Position: Moving from the upright to the supine position shifts the abdominal viscera cephalad against the diaphragm, reducing FRC by 0.5 to 1.0 L 0.5\text{ to }1.0\text{ L} 0.5 to 1.0 L (a ≈ 25 − 30 % \approx 25-30\% ≈ 25 − 30% reduction, primarily at the expense of ERV).

General Anaesthesia: Induction of general anaesthesia (whether via volatile or intravenous agents) eliminates diaphragmatic and intercostal muscle tone. Within minutes of induction, the diaphragm shifts cephalad by ≈ 2 cm \approx 2\text{ cm} ≈ 2 cm , reducing FRC by an additional 15 % to 20 % 15\%\text{ to }20\% 15% to 20% (roughly 400 − 500 mL 400-500\text{ mL} 400 − 500 mL in adults), regardless of whether spontaneous or mechanical ventilation is used.

Body Mass Index: In obesity, excess adipose tissue on the chest wall and abdomen decreases chest wall compliance, markedly reducing ERV and FRC.

Pregnancy: By the third trimester, the gravid uterus elevates the diaphragm, reducing FRC by 20 − 25 % 20-25\% 20 − 25% while metabolic oxygen consumption increases by 30 − 40 % 30-40\% 30 − 40% , accelerating hypoxemic desaturation during induction.

Surgical Interventions: Steep Trendelenburg positioning, peritoneal insufflation with CO 2 \text{CO}_2 CO 2 ​ (laparoscopic pneumoperitoneum), and upper abdominal surgical packs/retractors directly displace the diaphragm cephalad, precipitating severe FRC loss.

Closing Volume (CV) and Closing Capacity (CC)

Small peripheral conducting airways (diameter < 1 mm <1\text{ mm} < 1 mm ) lack cartilaginous support and depend entirely on radial traction exerted by surrounding alveolar elastic tissue to maintain patency. During forced exhalation, intrapleural pressure becomes positive, compressing peripheral airways.

Closing Volume (CV): The volume of gas exhaled between the onset of small airway closure in dependent lung bases and the end of a maximal expiration.

Closing Capacity (CC): The absolute volume of gas in the lungs at which airway closure begins: C C = C V + R V CC = CV + RV CC = C V + R V .

Closing Capacity versus FRC Relationships:

Erect Young Adult: F R C ≫ C C FRC \gg CC FRC ≫ CC . Airway closure occurs only near the very end of maximal expiration.

Supine at Age ≈ 44 \approx 44 ≈ 44 Years: Due to age-dependent loss of lung elastic recoil and the gravity-dependent cephalad diaphragmatic shift, CC equals FRC in the supine position.

Erect at Age ≈ 65 \approx 65 ≈ 65 Years: CC equals FRC in the upright position.

Under Anaesthesia: When FRC falls below CC ( F R C < C C FRC < CC FRC < CC ), small dependent airways close during normal tidal breathing. Alveolar gas distal to collapsed airways is absorbed into the pulmonary circulation, causing compression and absorption atelectasis , intrapulmonary shunt, and arterial hypoxemia.

  • 3. Compliance and Elastance of the Respiratory System
  • Definitions and Physical Principles

Elastance ( E E E ): The measure of the elastic resistance to deformation, defined as change in pressure per unit change in volume: E = Δ P Δ V E = \frac{\Delta P}{\Delta V} E = Δ V Δ P ​ .

Compliance ( C C C ): The measure of distensibility, defined as the volume change per unit change in distending pressure: C = Δ V Δ P = 1 E C = \frac{\Delta V}{\Delta P} = \frac{1}{E} C = Δ P Δ V ​ = E 1 ​ .

The total respiratory system consists of two elastic structures arranged in series: the lungs and the chest wall. Because pressures are additive ( P total = P lung + P chest P_{\text{total}} = P_{\text{lung}} + P_{\text{chest}} P total ​ = P lung ​ + P chest ​ ), their elastances add directly, and their compliances add as reciprocals:

1 C total = 1 C lung + 1 C chest \frac{1}{C_{\text{total}}} = \frac{1}{C_{\text{lung}}} + \frac{1}{C_{\text{chest}}} C total ​ 1 ​ = C lung ​ 1 ​ + C chest ​ 1 ​

In a conscious, healthy adult: C lung ≈ 200 mL/cmH 2 O C_{\text{lung}} \approx 200\text{ mL/cmH}_2\text{O} C lung ​ ≈ 200 mL/cmH 2 ​ O and C chest ≈ 200 mL/cmH 2 O C_{\text{chest}} \approx 200\text{ mL/cmH}_2\text{O} C chest ​ ≈ 200 mL/cmH 2 ​ O . Therefore:

1 C total = 1 200 + 1 200 = 2 200 ⟹ C total ≈ 100 mL/cmH 2 O \frac{1}{C_{\text{total}}} = \frac{1}{200} + \frac{1}{200} = \frac{2}{200} \implies C_{\text{total}} \approx 100\text{ mL/cmH}_2\text{O} C total ​ 1 ​ = 200 1 ​ + 200 1 ​ = 200 2 ​ ⟹ C total ​ ≈ 100 mL/cmH 2 ​ O

Under general anaesthesia and endotracheal intubation, normal static respiratory system compliance declines to approximately 50 − 70 mL/cmH 2 O 50-70\text{ mL/cmH}_2\text{O} 50 − 70 mL/cmH 2 ​ O .

  • Static vs Dynamic Compliance Pressure
  • ^
  • | /\ Peak Inspiratory Pressure (Ppeak)
  • | / \________________
  • | / | | Plateau Pressure (Pplat)
  • | / | Dynamic |
  • | / | Compliance | Static Compliance
  • | / | Component | Component
  • | / | (Flow-dep.) | (Elastic recoil only)
  • | / | |
  • +---------------------------------> Time
  • [ Flow > 0 ] [ End-Inspiratory Pause (Flow = 0) ]

Static Compliance ( C stat C_{\text{stat}} C stat ​ ): Assessed when gas flow is zero during an end-inspiratory hold (pause). Because flow velocity is zero, no pressure is dissipated to overcome airway resistance. It reflects purely elastic properties of the lung and chest wall: C stat = V T P plat − PEEP C_{\text{stat}} = \frac{V_T}{P_{\text{plat}} - \text{PEEP}} C stat ​ = P plat ​ − PEEP V T ​ ​ Normal in ventilated adults: 60 − 100 mL/cmH 2 O 60-100\text{ mL/cmH}_2\text{O} 60 − 100 mL/cmH 2 ​ O .

Dynamic Compliance ( C dyn C_{\text{dyn}} C dyn ​ ): Calculated from the peak inspiratory pressure during active gas delivery. It reflects both the elastic recoil of the system and the frictional resistance opposed to gas movement through conducting airways and the endotracheal tube: C dyn = V T P peak − PEEP C_{\text{dyn}} = \frac{V_T}{P_{\text{peak}} - \text{PEEP}} C dyn ​ = P peak ​ − PEEP V T ​ ​ Normal in ventilated adults: 40 − 70 mL/cmH 2 O 40-70\text{ mL/cmH}_2\text{O} 40 − 70 mL/cmH 2 ​ O .

Clinical Interpretation of Airway Pressures

Mechanical Scenario P peak P_{\text{peak}} P peak ​ P plat P_{\text{plat}} P plat ​ Driving Pressure ( P plat − PEEP P_{\text{plat}} - \text{PEEP} P plat ​ − PEEP ) Primary Underlying Pathology

High Airway Resistance Elevated Normal Normal Bronchospasm, secretions, endotracheal tube kinking, foreign body, patient biting tube.

Low Compliance (Stiff Lungs/Chest) Elevated Elevated Elevated Mainstem endobronchial intubation, tension pneumothorax, pulmonary edema, atelectasis, abdominal insufflation.

Driving Pressure Clinical Pearl: Keeping the driving pressure ( Δ P = P plat − PEEP \Delta P = P_{\text{plat}} - \text{PEEP} Δ P = P plat ​ − PEEP ) below 14 − 15 cmH 2 O 14-15\text{ cmH}_2\text{O} 14 − 15 cmH 2 ​ O significantly reduces barotrauma, volutrauma, and mortality in acute respiratory distress syndrome (ARDS).

  • 4. Airway Resistance and Flow Dynamics
  • Airway Resistance ( R aw R_{\text{aw}} R aw ​ )

Airway resistance represents the pressure gradient required to drive gas flow through the tracheobronchial tree:

R aw = Δ P V ˙ = P peak − P plat V ˙ R_{\text{aw}} = \frac{\Delta P}{\dot{V}} = \frac{P_{\text{peak}} - P_{\text{plat}}}{\dot{V}} R aw ​ = V ˙ Δ P ​ = V ˙ P peak ​ − P plat ​ ​

In a conscious, healthy adult, normal total airway resistance is 1.0 − 2.5 cmH 2 O / ( L/s ) 1.0-2.5\text{ cmH}_2\text{O}/(\text{L/s}) 1.0 − 2.5 cmH 2 ​ O / ( L/s ) . In an intubated patient on mechanical ventilation, normal values range between 5.0 and 10.0 cmH 2 O / ( L/s ) 5.0\text{ and }10.0\text{ cmH}_2\text{O}/(\text{L/s}) 5.0 and 10.0 cmH 2 ​ O / ( L/s ) , with the endotracheal tube accounting for up to 50 % 50\% 50% of the total resistance.

Anatomical Distribution of Resistance: Generations 4 to 8 (medium-sized bronchi with internal diameters of 2 − 5 mm 2-5\text{ mm} 2 − 5 mm ) account for the highest individual proportion of airway resistance. While individual terminal bronchioles have tiny radii, their parallel bifurcations generate an exponential increase in total cross-sectional surface area, rendering the terminal "silent zone" responsible for < 20 % <20\% < 20% of total airway resistance.

Laminar vs Turbulent Flow and Reynolds Number

Laminar Flow (Hagen-Poiseuille Law): Flow occurs in concentric streamlines with parabolic velocity profiles. Governed by: V ˙ = π ⋅ Δ P ⋅ r 4 8 ⋅ η ⋅ l ⟹ R = 8 ⋅ η ⋅ l π ⋅ r 4 \dot{V} = \frac{\pi \cdot \Delta P \cdot r^4}{8 \cdot \eta \cdot l} \implies R = \frac{8 \cdot \eta \cdot l}{\pi \cdot r^4} V ˙ = 8 ⋅ η ⋅ l π ⋅ Δ P ⋅ r 4 ​ ⟹ R = π ⋅ r 4 8 ⋅ η ⋅ l ​ Resistance is inversely proportional to the fourth power of the radius ( r 4 r^4 r 4 ) and depends on gas viscosity ( η \eta η ) , independent of gas density ( ρ \rho ρ ). A 50 % 50\% 50% reduction in airway radius increases resistance 16-fold.

Turbulent Flow: Streamlines break down into chaotic vortices. Pressure drop is proportional to the square of flow velocity ( Δ P ∝ V ˙ 2 \Delta P \propto \dot{V}^2 Δ P ∝ V ˙ 2 ) and depends directly on gas density ( ρ \rho ρ ) , independent of viscosity.

Reynolds Number ( R e Re R e ): Dimensionless number predicting the transition from laminar to turbulent flow: R e = 2 ⋅ r ⋅ v ⋅ ρ η Re = \frac{2 \cdot r \cdot v \cdot \rho}{\eta} R e = η 2 ⋅ r ⋅ v ⋅ ρ ​ Where r r r is airway radius, v v v is linear flow velocity, ρ \rho ρ is gas density, and η \eta η is dynamic viscosity.

R e < 2000 Re < 2000 R e < 2000 : Flow is predominantly laminar.

R e > 2000 Re > 2000 R e > 2000 : Flow becomes turbulent.

Clinical Application (Heliox): In severe upper airway obstruction (croup, subglottic stenosis, tracheal tumors), flow in the large conducting airways is turbulent. Helium is substantially less dense than nitrogen (density of 80 : 20 80:20 80 : 20 Heliox is one-third that of air), decreasing R e Re R e , restoring laminar flow kinetics, and dramatically reducing the resistive work of breathing.

5. Work of Breathing (WOB)

The work performed by the respiratory muscles (or mechanical ventilator) during inspiration is defined as:

W = ∫ P ⋅ d V W = \int P \cdot dV W = ∫ P ⋅ d V

Work of breathing is visually depicted on a Campbell diagram (plotting transpulmonary pressure against lung volume) and divides into two physical components:

Elastic Work ( ≈ 65 % \approx 65\% ≈ 65% of total resting work): Work required to overcome the elastic recoil of lung parenchyma, chest wall structures, and alveolar surface tension. Elastic work is stored as potential energy during inspiration and powers passive exhalation.

Resistive Work ( ≈ 35 % \approx 35\% ≈ 35% of total resting work): Work dissipated as heat to overcome frictional forces:

Airway resistance (viscous work of gas flow, ≈ 28 % \approx 28\% ≈ 28% )

Tissue viscous resistance (deformation of pulmonary and thoracic soft tissues, ≈ 7 % \approx 7\% ≈ 7% ) Work Rate

  • ^
  • | \ / Total Work Curve
  • | \ Optimum (~12-15 bpm) /
  • | \ | /
  • | \ v /
  • | \___________.....___________/
  • | \ / Elastic Work
  • | \ / (Increases at low RR/high VT)
  • | \ /
  • | ---------------------
  • | / \ Resistive Work
  • | / \ (Increases at high RR/high flow)
  • +-----------------------------------------> Respiratory Rate
  • Optimization of Respiratory Rate

Total work of breathing exhibits a minimum at a normal resting respiratory rate of 12 − 15 breaths/min 12-15\text{ breaths/min} 12 − 15 breaths/min :

Restrictive Lung Disease (e.g. pulmonary fibrosis, ARDS): High elastic recoil shifts the work minimum to the right. Patients spontaneously adopt a rapid, shallow breathing pattern to minimize elastic work.

Obstructive Lung Disease (e.g. severe asthma, COPD): High airway resistance shifts the work minimum to the left. Patients spontaneously adopt a slow, deep breathing pattern to minimize resistive work.

  • 6. Pulmonary Surfactant Biophysics
  • Composition and Cellular Origin

Pulmonary surfactant is synthesized, stored in lamellar bodies, and secreted into the alveolar hypophase by Type II alveolar epithelial cells (pneumocytes) , which constitute 60 % 60\% 60% of alveolar epithelial cells but cover only 5 − 10 % 5-10\% 5 − 10% of the alveolar surface area.

Lipids ( 90 % 90\% 90% ): Primarily dipalmitoylphosphatidylcholine (DPPC) , an amphipathic phospholipid with hydrophobic palmitic acid tails directed toward the alveolar air phase and hydrophilic choline heads directed toward the aqueous hypophase.

Proteins ( 10 % 10\% 10% ): Four surfactant-associated apoproteins:

SP-B and SP-C (Hydrophobic): Essential for spreading and stabilizing the DPPC phospholipid monolayer across the alveolar interface.

SP-A and SP-D (Hydrophilic): Collectins involved in innate host immune defense and opsonization of pathogens.

Law of Laplace and Surfactant Function

Alveoli behave mechanically as fluid-lined spherical structures. The transmural collapsing pressure is described by Laplace's Law for a sphere:

P = 2 T r P = \frac{2T}{r} P = r 2 T ​

Where P P P is the inward collapsing pressure, T T T is the surface tension of the liquid lining, and r r r is the alveolar radius. WITHOUT SURFACTANT (Constant Surface Tension T = 50 mN/m):

  • Small Alveolus (r = 50 um) Large Alveolus (r = 100 um)
  • P = 2(50) / 50 = 2.0 kPa P = 2(50) / 100 = 1.0 kPa
  • [ High P ] ===================> [ Low P ]
  • Small alveolus empties into large alveolus (Atelectasis!)

WITH SURFACTANT (Variable Surface Tension T proportional to r):

  • Small Alveolus (r = 50 um, T = 5 mN/m) Large Alveolus (r = 100 um, T = 10 mN/m)
  • P = 2(5) / 50 = 0.2 kPa P = 2(10) / 100 = 0.2 kPa

Pressures equalize -> Both alveoli remain stable!

Surfactant Mechanisms:

Alveolar Stabilization: Without surfactant, smaller alveoli would have higher internal collapsing pressures than adjacent larger alveoli, causing smaller alveoli to empty into larger ones (Laplace instability). As an alveolus deflates, DPPC molecules become tightly packed, reducing surface tension from ≈ 50 mN/m \approx 50\text{ mN/m} ≈ 50 mN/m to near 0 − 5 mN/m 0-5\text{ mN/m} 0 − 5 mN/m . This equalizes pressures across interconnected alveoli of differing diameters.

Augmentation of Compliance: By lowering surface tension, surfactant markedly increases lung compliance, drastically reducing the muscular work required for lung expansion.

Prevention of Alveolar Edema: Inward collapsing pressure creates a negative hydrostatic vector pulling fluid from the pulmonary capillaries into the alveolar space. By reducing surface tension, surfactant prevents hydrostatic pulmonary edema.